Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - Krystal Biotech, Inc. | krys-ex322_10.htm |
| EX-32.1 - EX-32.1 - Krystal Biotech, Inc. | krys-ex321_7.htm |
| EX-31.2 - EX-31.2 - Krystal Biotech, Inc. | krys-ex312_11.htm |
| EX-31.1 - EX-31.1 - Krystal Biotech, Inc. | krys-ex311_9.htm |
| EX-21.1 - EX-21.1 - Krystal Biotech, Inc. | krys-ex211_78.htm |
| EX-10.16 - EX-10.16 ASTRA LEASE - Krystal Biotech, Inc. | krys-ex1016_82.htm |
| EX-10.15 - EX-10.15 WHARTON LEASE 5TH AMENDMENT - Krystal Biotech, Inc. | krys-ex1015_81.htm |
| EX-10.14 - EX-10.14 WHARTON LEASE 4TH AMENDMENT - Krystal Biotech, Inc. | krys-ex1014_79.htm |
| EX-10.13 - EX-10.13 WHARTON LEASE 3RD AMENDMENT - Krystal Biotech, Inc. | krys-ex1013_80.htm |
| EX-4.3 - EX-4.3 DESCRIPTION OF COMMON STOCK - Krystal Biotech, Inc. | krys-ex43_128.htm |
| 10-K - 10-K - Krystal Biotech, Inc. | krys-10k_20191231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statements:
|
(1) |
Registration Statement (Form S-8 No. 333-220589) of Krystal Biotech, Inc.; and |
|
(2) |
Registration Statement (Form S-3 No. 333-227632) of Krystal Biotech, Inc.; |
of our report dated March 10, 2020, relating to the financial statements of Krystal Biotech, Inc. included in this Annual Report (Form 10-K) as of December 31, 2019 and 2018 and for the two years then ended.
/s/ Mayer Hoffman McCann P.C.
San Diego, California
March 10, 2020